Abstract
Objective: Barth syndrome is an X-linked recessive disorder characterized by dilated cardiomyopathy, neutropenia, 3-methylglutaconic aciduria, abnormal mitochondria, variably expressed skeletal myopathy, and growth delay. The disorder is caused by mutations in the tafazzin (TAZ/G4.5) gene located on Xq28. We report a novel exonic splicing mutation in the TAZ gene in a patient with atypical Barth syndrome.
Patient & Methods: The 4-month-old proband presented with respiratory distress, neutropenia, and dilated cardiomyopathy with reduced ejection fraction of 10%. No 3-methylglutaconic aciduria was detected on repeated urine organic acid analyses. Family history indicated that his maternal uncle died of endocardial fibroelastosis and dilated cardiomyopathy at 26 months. TAZ DNA sequencing, mRNA analysis, and cardiolipin analysis were performed.
Results: A novel nucleotide substitution c.553A>G in exon 7 of the TAZ gene was identified in the proband, predicting an amino acid substitution p.Met185Val. However, this mutation created a new splice donor signal within exon 7 causing mis-splicing of the message, producing two messages that only differ in the presence/absence of exon 5; these retain intron 6 and have only 11 bases of exon 7. Cardiolipin analysis confirmed the loss of tafazzin activity. The proband’s mother, maternal aunt, and grandmother carry the same mutation.
Conclusions: The identification of a TAZ gene mutation, mRNA analysis, and monolysocardiolipin/cardiolipin ratio determination were important for the diagnosis and genetic counseling in this family with atypical Barth syndrome that was not found to be associated with 3-methylglutaconic aciduria.
Competing interests: None declared
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 3-MGCA:
-
3-methylglutaconic acid
- BNP:
-
Brain natriuretic peptide
- BTHS:
-
Barth Syndrome
- hs-CRP:
-
High sensitivity C-reactive protein
- MLCL/CL:
-
Monolysocardiolipin/cardiolipin
- TAZ :
-
Tafazzin
References
Barth PG, Scholte HR, Berden JA et al (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62(1–3):327–355
Barth PG, Wanders RJ, Vreken P (1999) X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060. J Pediatr 135(3):273–276
Barth PG, Valianpour F, Bowen VM et al (2004) X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet A 126A(4):349–354
Bione S, D'Adamo P, Maestrini E et al (1996) A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 12(4):385–389
Bleyl SB, Mumford BR, Thompson V et al (1997) Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 61(4):868–872
Brady AN, Shehata BM, Fernhoff PM (2006) X-linked fetal cardiomyopathy caused by a novel mutation in the TAZ gene. Prenat Diagn 26(5):462–465
Cantlay AM, Shokrollahi K, Allen JT et al (1999) Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J Pediatr 135(3):311–315
Chen R, Tsuji T, Ichida F et al (2002) Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol Genet Metab 77(4):319–325
Clarke SL, Bowron A, Gonzalez IL et al (2013) Barth syndrome. Orphanet J Rare Dis 8:23
D'Adamo P, Fassone L, Gedeon A et al (1997) The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 61(4):862–867
Dogan RI, Getoor L, Wilbur WJ et al (2007) SplicePort–an interactive splice-site analysis tool. Nucleic Acids Res 35(Web Server issue):W285–W291, Epub 2007 Jun 18
Gedeon AK, Wilson MJ, Colley AC et al (1995) X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome. J Med Genet 32:383–388
Gonzalez IL (2005) Barth syndrome: TAZ gene mutations, mRNAs, and evolution. Am J Med Genet A 134(4):409–414
Houtkooper RH, Rodenburg RJ, Thiels C et al (2009) Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal Biochem 387(2):230–237
Johnston J, Kelley RI, Feigenbaum A et al (1997) Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am J Hum Genet 61(5):1053–1058
Kelley RI, Cheatham JP, Clark BJ et al (1991) X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 119(5):738–747
Kulik W, van Lenthe H, Stet FS et al (2008) Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome. Clin Chem 54(2):371–378
Malhotra A, Edelman-Novemsky I, Xu Y et al (2009) Role of calcium-independent phospholipase A2 in the pathogenesis of Barth Syndrome. Proc Natl Acad Sci U S A 106(7):2337–2341
Marziliano N, Mannarino S, Nespoli L et al (2007) Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet A 143A(9):907–915
Roberts AE, Nixon C, Steward CG et al (2012) The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study. Am J Med Genet Part A 158A:2726–2732
Sakamoto O, Ohura T, Katsushima Y et al (2001) A novel intronic mutation of the TAZ ( G4.5) gene in a patient with Barth syndrome: creation of a 5' splice donor site with variant GC consensus and elongation of the upstream exon. Hum Genet 109(5):559–563
Sakamoto O, Kitoh T, Ohura T et al (2002) Novel missense mutation (R94S) in the TAZ (G4.5) gene in a Japanese patient with Barth syndrome. J Hum Genet 47(5):229–231
Schlame M, Rua D, Greenberg ML (2000) The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39(3):257–288
Schlame M, Towbin JA, Heerdt PM et al (2002) Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51(5):634–637
Schlame M, Ren M (2006) Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580(23):5450–5455
Schmidt MR, Birkebaek N, Gonzalez I et al (2004) Barth syndrome without 3-methylglutaconic aciduria. Acta Paediatr 93(3):419–421
Spencer CT, Bryant RM, Day J et al (2006) Cardiac and clinical phenotype in Barth syndrome. Pediatrics 118(2):e337–e346
Steward CG, Newbury-Ecob RA, Hastings R et al (2010) Barth Syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenal Diagn 30(10):970–976
Valianpour F, Wanders RJ, Overmars H et al (2002) Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts. J Pediatr 141(5):729–733
Vreken P, Valianpour F, Nijtmans LG et al (2000) Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 279(2):378–382
Xu Y, Condell M, Plesken H et al (2006) A Drosophila model of Barth syndrome. Proc Natl Acad Sci U S A 103(31):11584–11588
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Additional information
Communicated by: Eva Morava, MD PhD
Appendices
Synopsis
We present a novel exonic splicing mutation in the TAZ gene in a patient with an atypical presentation of Barth syndrome lacking one of the cardinal signs: 3-methylglutaconic aciduria.
Conflicts of Interest
There are no conflicts of interest.
Rights and permissions
Copyright information
© 2013 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fan, Y. et al. (2013). A Novel Exonic Splicing Mutation in the TAZ (G4.5) Gene in a Case with Atypical Barth Syndrome. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports - Volume 11. JIMD Reports, vol 11. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2013_228
Download citation
DOI: https://doi.org/10.1007/8904_2013_228
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37327-5
Online ISBN: 978-3-642-37328-2
eBook Packages: MedicineMedicine (R0)